RxDoctor Payments Data

Ronald Freudenberger

Advanced Heart Failure and Transplant Cardiology · Allentown, PANPI 1750451332

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (50.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Medtronic at 50.6% of the total. Reporting peaked in 2022 at $11,808 and has fallen 94.4% since, to $666 in 2025.

$27,891in general payments, 2019–2025

Across 140 payments — averaging $199.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$14K
  • Boston Scientific$12K
  • Abbott$961
  • GE HealthCare$206
  • Shockwave Medical, Inc$170
  • Biosense Webster, Inc.$138
  • plus $470 from 6 others
$39,397in research payments, 2019–2025

Across 16 payments — averaging $2462.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$14K
  • Boston Scientific$13K
  • Medtronic$12K

What the payments were for

  • Consulting fees$14,15051%
  • Travel & lodging$4,40116%
  • Food & beverage$9,34033%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,891 in reported general payments places this provider in the 75th percentile of 96 advanced heart failure and transplant cardiology providers in Pennsylvania.

See all advanced heart failure and transplant cardiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$36,715
Medicare patients
203
Services billed
489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan171$190,354
EliquisApixaban96$113,915
JardianceEmpagliflozin27$44,960
Repatha SureclickEvolocumab24$24,540
XareltoRivaroxaban16$23,479
Metoprolol Succinate258$4,698
Dofetilide12$4,187
PlavixClopidogrel Bisulfate11$3,193
Torsemide82$2,826
Atorvastatin Calcium186$2,475
Bisoprolol Fumarate54$1,727
ClopidogrelClopidogrel Bisulfate118$1,380
Spironolactone99$1,238
Digoxin36$1,226
Carvedilol92$1,221

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in Allentown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →